ProQR Therapeutics NV (PRQR)
1.96
-0.05
(-2.49%)
USD |
NASDAQ |
Apr 25, 16:00
ProQR Therapeutics Cash from Operations (TTM): 23.33M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.33M |
| September 30, 2023 | 8.056M |
| June 30, 2023 | 2.851M |
| March 31, 2023 | -1.246M |
| December 31, 2022 | -72.25M |
| September 30, 2022 | -46.69M |
| June 30, 2022 | -42.19M |
| March 31, 2022 | -39.57M |
| December 31, 2021 | -30.78M |
| September 30, 2021 | -47.59M |
| June 30, 2021 | -51.87M |
| March 31, 2021 | -51.36M |
| December 31, 2020 | -53.74M |
| September 30, 2020 | -54.91M |
| June 30, 2020 | -51.19M |
| March 31, 2020 | -51.74M |
| December 31, 2019 | -49.22M |
| September 30, 2019 | -46.69M |
| June 30, 2019 | -41.68M |
| Date | Value |
|---|---|
| March 31, 2019 | -35.76M |
| December 31, 2018 | -33.64M |
| September 30, 2018 | -31.29M |
| June 30, 2018 | -37.16M |
| March 31, 2018 | -42.15M |
| December 31, 2017 | -39.58M |
| September 30, 2017 | -38.70M |
| June 30, 2017 | -40.18M |
| March 31, 2017 | -38.66M |
| December 31, 2016 | -37.87M |
| September 30, 2016 | -37.51M |
| June 30, 2016 | -32.71M |
| March 31, 2016 | -29.51M |
| December 31, 2015 | -26.89M |
| September 30, 2015 | -26.07M |
| June 30, 2015 | -24.50M |
| March 31, 2015 | -22.52M |
| December 31, 2014 | -19.23M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-72.25M
Minimum
Dec 2022
23.33M
Maximum
Dec 2023
-36.76M
Average
-46.69M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
| uniQure NV | -145.93M |
| Merus NV | -142.21M |
| argenx SE | -- |
| Pharming Group | -17.30M |
| Pharvaris NV | -100.74M |